— Know what they know.
Not Investment Advice

SRBCF OTC

Sirona Biochem Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -57.9% 3Y: -97.1% 5Y: -90.4%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $1.6M mcap · 245M float · 0.0000% daily turnover · Short 7% of daily vol

Income Trends

Revenue
$35K -94.8% ▼
5Y CAGR: -51.4%
Gross Profit
-$29K -104.6% ▼
Operating Income
-$2M +32.6% ▲
Net Income
-$3M +28.5% ▲
EPS (Diluted)
$-0.01 +31.8% ▲
EBITDA
-$2M +33.6% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$136K$106K$268K$672K$35K
YoY Growth-89.4%-22.1%+153.5%+150.7%-94.8%
Cost of Revenue$0$54K$69K$50K$64K
Gross Profit$136K$52K$199K$622K-$29K
Gross Margin100.0%48.8%74.3%92.5%-82.7%
R&D Expenses$1M$1M$1M$1M$1M
SG&A Expenses$3M$3M$1M$3M$930K
Operating Expenses$5M$4M$3M$4M$2M
Operating Income-$4M-$4M-$2M-$4M-$2M
Operating Margin-3273.5%-3821.3%-875.8%-531.1%-6917.6%
Interest Expense$117K$13K$3K$27K$202K
Income Before Tax-$5M-$4M-$2M-$4M-$3M
Tax Expense-$6K-$7K-$6K$6K-$954
Net Income-$5M-$4M-$2M-$4M-$3M
Net Margin-3351.6%-3910.4%-860.5%-529.5%-7312.4%
EPS (Diluted)$-0.02$-0.02$-0.01$-0.01$-0.01
EBITDA$0-$4M-$2M-$4M-$2M
Shares Outstanding201M226M229M241M252M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms